Business Context and Reporting Period
This Form 8-K, dated June 5, 2026, reports a material definitive agreement entered into by Bally's Corporation (the "Company"). The filing concerns Bally's Intralot S.A. ("Bally's Intralot"), a Greek publicly listed company in which the Company holds approximately 59.44% of outstanding shares as of March 31, 2026. The agreement involves the acquisition of Evoke PLC, a Gibraltar-based company listed on the London Stock Exchange.
Key Financial Metrics and Transaction Terms
The transaction is an all-share acquisition valued at approximately £243.1 million, based on a share price of €1.12 for Bally's Intralot. Key financial terms include:
- Exchange Ratio: Evoke shareholders receive 0.537 new Bally's Intralot shares for each Evoke share (valued at ~52 pence per share).
- Cash Alternative: Shareholders may elect a cash payment of 52 pence per share, capped at an aggregate £117.1 million.
- Financing Structure:
- Bridge facility of up to €200 million from Deutsche Bank and Jefferies to fund cash consideration.
- Second lien term facility of up to the EUR equivalent of £889 million to refinance Evoke's 2028 senior indebtedness.
- Senior facility of £157 million from institutional investors.
- Expansion of Evoke's revolving credit facility to £220 million.
- Debt Obligations: Bally's Intralot must fund a mandatory repayment of the EUR equivalent of £200 million by December 31, 2027, and synergy-related costs up to £50 million.
Material Changes and Conditions
The acquisition is conditional upon several approvals, including:
- Approval by Evoke shareholders of the scheme of arrangement.
- Approval by Bally's Intralot shareholders to authorize the issuance of new shares.
- Customary regulatory, gaming, anti-trust, and foreign direct investment clearances.
Bally's Corporation has agreed to exercise its voting rights in favor of the necessary resolutions at Bally's Intralot shareholder meetings, including amendments to the articles of association to permit incoming shareholders to appoint a nominee director.
Outlook and Management Commentary
The acquisition is expected to conclude between the final quarter of 2026 and the first quarter of 2027. The transaction is structured as a scheme of arrangement under Part VIII of the Gibraltar Companies Act. The filing does not provide specific revenue, profit, or cash flow projections for the combined entity, nor does it detail specific synergy targets beyond the capped funding commitment.
Investor Verification Checklist
- Verify the final approval status of the scheme of arrangement by Evoke and Bally's Intralot shareholders.
- Monitor regulatory clearance progress, specifically gaming and anti-trust approvals in relevant jurisdictions.
- Confirm the actual utilization of the £117.1 million cash alternative cap versus the share exchange ratio.
- Review the terms of the second lien term facility and the mandatory repayment schedule for the £200 million obligation due in 2027.
- Assess the impact of the new debt facilities on Bally's Intralot's leverage ratios and liquidity position.